Vulpes Ventures — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Oxford Biodynamicsoxfordbiodynamics.com in 𝕏Oct 2021SEC filingmedium confidence

Oxford BioDynamics develops precision clinical diagnostic blood tests for detecting cancer and predicting treatment response in cancer patients, using its proprietary 3D genomic biomarker platform.

BiotechDigital HealthMedical DevicesOxford, GB

Alexandre Akoulitchev(Director)Jon Burrows(Chief Executive Officer)inPaul Stockdale(Chief Financial Officer)

BoardDavid Holbrook(Director)Matthew Wakefield(Director)

Board seatStephen Diggle· per SEC Form D · $5M raise · filed Nov 2021

Co-investorsSeneca Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

JigSpace

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.